Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 17%
Buy 50%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors is expected to experience a decline in FFOps in 2026 due to the projected rent reset for Bickford Senior Living; however, it is projected to see an overall increase in FFOps from 2026-2031. The company's focus on senior housing and healthcare properties, combined with its diverse financing options, positions it well for long-term growth potential. The proposed sale of a skilled nursing portfolio may cause a short-term dip in NOI, but it will also provide the company with a significant amount of capital for future growth opportunities. Overall, National Health Investors' strategic plans align with industry trends and its strong financial position makes it an attractive investment opportunity.

Bears say

National Health Investors is facing challenges in the near term due to the lower-than-expected outcome of the NHC portfolio sale and reduced earnings estimates. The company's high operator concentration and increased reliance on RIDEA could also lead to potential risks and volatility. There is a potential for higher-than-expected growth in the long term due to the company's low-levered balance sheet and attractive cost of capital, but investors should closely monitor the management's execution in diversifying the portfolio and ensuring organic growth in the senior housing market.

NHI has been analyzed by 6 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 50% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 6 analysts, NHI has a Buy consensus rating as of Aug 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.